|Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Since it discovered that the substance which expands the projection of a nerve cell from Candida yeast, and supports growth existed, chemical synthesis was performed based on the composition and structure(with the similar object of NAD, a molecular weight is 663), and synthetic compound was obtained. The obtained compound expanded notably the projection of the rat central-nerves cell and the human origin nerve cell(NB-1). Moreover, it was checked that a series of gene clusters which participate in extension of a nerve projection of any cell, substance transportation, microtubule stability, etc. are revealed strongly.
Compound which is proposed in this research differs from any which are reported so far completely, peptide and the lipid is not included, it is possible to synthesize easily. The synthetic compound brought about extension of a projection of a nerve cell, and extension of survival of the cells which is in a starvation situation. As for this result, protection of the nerve cell which has a synthetic compound under various diseases of the nervous system, especially an ischemia situation, restoration, reproduction, etc. are expected to demonstrate an effect, and leading to creation of a new diseases-of-the-nervous-system curative medicine is suggested. Patent application No.2010-154279 PCT : PCT/JP2011/002319
The applicable field of the compound proposed by this research is as follows. Diseases-of-the-nervous-system medical treatment, medicine development, regenerative medicine, a cell technology, neuronal physiology, neuroscience, etc.